GlassScriptPhysician profile
Hea R Kwon
NPI 1598023582
$2,504.98
in general payments reported to CMS, 2019-2025
20 companies · $659 in 2025
The $659 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $347 · 2023: $587 · 2024: $789 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,035.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $545.53 | 2021-2025 | |
| Novo Nordisk INC | $403.66 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $293.85 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Sumitomo Pharma America, INC. | $215.63 | 2024-2025 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $207.37 | 2024-2025 | Trintellix |
| Amgen INC. | $148.30 | 2023-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $131.75 | 2023-2024 | Myrbetriq, Veozah |
| Exact Sciences Corporation | $84.03 | 2024-2025 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $83.06 | 2024 | |
| Phathom Pharmaceuticals, INC. | $76.09 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $74.11 | 2024-2025 | Capvaxive |
| Ironwood Pharmaceuticals, INC | $45.01 | 2024 | |
| Amarin Pharma, INC. | $39.32 | 2022-2023 | |
| Vbi Vaccine (Delaware) INC. | $27.35 | 2022 | |
| Pfizer INC. | $25.00 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $22.50 | 2023 | |
| Arbor Pharmaceuticals, INC. | $22.23 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.69 | 2023 | |
| Glaxosmithkline, LLC. | $19.94 | 2024 | Shingrix, Arexvy |
| Eisai INC. | $18.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hea Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.